213 related articles for article (PubMed ID: 33420370)
1. Hypoxia-induced PLOD1 overexpression contributes to the malignant phenotype of glioblastoma via NF-κB signaling.
Wang Z; Shi Y; Ying C; Jiang Y; Hu J
Oncogene; 2021 Feb; 40(8):1458-1475. PubMed ID: 33420370
[TBL] [Abstract][Full Text] [Related]
2. PLOD1 Is a Prognostic Biomarker and Mediator of Proliferation and Invasion in Osteosarcoma.
Jiang H; Guo W; Yuan S; Song L
Biomed Res Int; 2020; 2020():3418398. PubMed ID: 33134376
[TBL] [Abstract][Full Text] [Related]
3. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
[TBL] [Abstract][Full Text] [Related]
4. PLOD1 acts as a tumor promoter in glioma via activation of the HSF1 signaling pathway.
Yuan B; Xu Y; Zheng S
Mol Cell Biochem; 2022 Feb; 477(2):549-557. PubMed ID: 34845571
[TBL] [Abstract][Full Text] [Related]
5. Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.
Li Y; Wang X; Qi S; Gao L; Huang G; Ren Z; Li K; Peng Y; Yi G; Guo J; Yang R; Wang H; Zhang X; Liu Y
Neuro Oncol; 2021 Oct; 23(10):1693-1708. PubMed ID: 34042961
[TBL] [Abstract][Full Text] [Related]
6. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
[TBL] [Abstract][Full Text] [Related]
7. CLEC19A overexpression inhibits tumor cell proliferation/migration and promotes apoptosis concomitant suppression of PI3K/AKT/NF-κB signaling pathway in glioblastoma multiforme.
Mohajerani F; Tehrankhah ZM; Rahmani S; Afsordeh N; Shafiee S; Pourgholami MH; Soltani BM; Sadeghizadeh M
BMC Cancer; 2024 Jan; 24(1):19. PubMed ID: 38167030
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
9. High Expression of PLOD1 Drives Tumorigenesis and Affects Clinical Outcome in Gastrointestinal Carcinoma.
Wang D; Zhang S; Chen F
Genet Test Mol Biomarkers; 2018 Jun; 22(6):366-373. PubMed ID: 29723071
[TBL] [Abstract][Full Text] [Related]
10. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
11. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
Wang H; Li L; Yin L
Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
[TBL] [Abstract][Full Text] [Related]
12. NFAT2-HDAC1 signaling contributes to the malignant phenotype of glioblastoma.
Song Y; Jiang Y; Tao D; Wang Z; Wang R; Wang M; Han S
Neuro Oncol; 2020 Jan; 22(1):46-57. PubMed ID: 31400279
[TBL] [Abstract][Full Text] [Related]
13. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
[TBL] [Abstract][Full Text] [Related]
14. PLOD1, a target of miR-34c, contributes to cell growth and metastasis via repressing LATS1 phosphorylation and inactivating Hippo pathway in osteosarcoma.
Wu X; Xiang H; Cong W; Yang H; Zhang G; Wang Y; Guo Z; Shen Y; Chen B
Biochem Biophys Res Commun; 2020 Jun; 527(1):29-36. PubMed ID: 32446383
[TBL] [Abstract][Full Text] [Related]
15. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract][Full Text] [Related]
16. PLOD1 promotes cell growth and aerobic glycolysis by regulating the SOX9/PI3K/Akt/mTOR signaling pathway in gastric cancer.
Zhang Y; Wu Y; Su X
Front Biosci (Landmark Ed); 2021 Aug; 26(8):322-334. PubMed ID: 34455762
[No Abstract] [Full Text] [Related]
17. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X
J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway.
Zhong X; Cai Y
Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389
[TBL] [Abstract][Full Text] [Related]
20. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
